{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:26:03Z","timestamp":1787286363250,"version":"build-2736575974"},"reference-count":39,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"R\u00e9gion Grand Est"},{"name":"Nancyclotep"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>The development of hybrid bifunctional chelators (BFCs) capable of efficiently coordinating both diagnostic and therapeutic radionuclides remains a major challenge in theranostic radiopharmaceutical design. Herein, two novel hybrid NOTA-derived chelators, NO2A-2C-AHM and NODAGA-HM, were developed from the previously reported NO2A-AHM BFC to improve the coordination of 177Lu while preserving efficient Al18F labeling. Both ligands were successfully synthesized and fully characterized by NMR and mass spectrometry analyses. Their coordination properties toward {AlF}2+ and Lu3+ were thoroughly investigated by molecular modeling, non-radioactive complexation, and radiolabeling studies. Both chelators efficiently formed AlF complexes, exhibiting high complexation yields and successful Al18F radiolabeling with good stability. In contrast, only NODAGA-HM efficiently coordinated Lu3+, whereas NO2A-2C-AHM failed to form stable Lu complexes under both non-radioactive and radiolabeling conditions. Optimized radiolabeling of NODAGA-HM with 177Lu afforded high radiochemical conversion, consistent with the molecular modeling predictions. These results demonstrate that the spatial positioning of the additional donor arm, rather than linker elongation alone, is a key determinant for efficient coordination of larger trivalent radiometals. Thus, NODAGA-HM emerged as the most promising candidate for further development of targeted radiopharmaceuticals based on the Al18F\/177Lu theranostic approach.<\/jats:p>","DOI":"10.3390\/ijms27167421","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:14:01Z","timestamp":1787145241000},"page":"7421","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Study of NOTA-Derived Chelators: Synthesis, Al18F\/177Lu Radiolabeling and Computational Analysis"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6899-6177","authenticated-orcid":false,"given":"Abir","family":"Dhimen","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Lorraine, CNRS, LRGP, F-54000 Nancy, France"},{"name":"Nancyclotep, Plateforme d\u2019Imagerie Mol\u00e9culaire, F-54511 Vand\u0153uvre-l\u00e8s-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-6825","authenticated-orcid":false,"given":"Xavier","family":"Assfeld","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, CNRS, LPCT, F-54000 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Karcher","sequence":"additional","affiliation":[{"name":"Nancyclotep, Plateforme d\u2019Imagerie Mol\u00e9culaire, F-54511 Vand\u0153uvre-l\u00e8s-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-6967","authenticated-orcid":false,"given":"Charlotte","family":"Collet","sequence":"additional","affiliation":[{"name":"Nancyclotep, Plateforme d\u2019Imagerie Mol\u00e9culaire, F-54511 Vand\u0153uvre-l\u00e8s-Nancy, France"},{"name":"Universit\u00e9 de Lorraine, INSERM, IADI, F-54000 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8776-1632","authenticated-orcid":false,"given":"Samir","family":"Acherar","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, CNRS, LRGP, F-54000 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref_1","first-page":"1085","article-title":"Therapeutic Radiopharmaceuticals","volume":"6","author":"Ercan","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Velikyan, I. (2020). (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer. Pharmaceuticals, 13.","DOI":"10.3390\/ph13030039"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical Therapy in Cancer: Clinical Advances and Chal-lenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S1470-2045(19)30821-6","article-title":"Radiotheranostics: A Roadmap for Future Development","volume":"21","author":"Herrmann","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejrad.2008.01.025","article-title":"Extracellular Gadolinium Contrast Agents: Differences in Stability","volume":"66","author":"Morcos","year":"2008","journal-title":"Eur. J. Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.3390\/molecules18033379","article-title":"Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases","volume":"18","author":"Jamous","year":"2013","journal-title":"Molecules"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bober, B., Saracyn, M., Zar\u0119ba, K., Lubas, A., Mazurkiewicz, P., Wili\u0144ska, E., and Kami\u0144ski, G. (2022). Early Complications of Radioi-sotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms\u2014A Preliminary Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11040919"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"113752","DOI":"10.1016\/j.ejmech.2021.113752","article-title":"PSMA-Targeted Low-Molecular Double Conju-gates for Diagnostics and Therapy","volume":"225","author":"Petrov","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/bc100137x","article-title":"Improved 18F La-beling of Peptides with a Fluoride-Aluminum-Chelate Compex","volume":"21","author":"McBride","year":"2010","journal-title":"Bioconjugate Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41181-021-00141-0","article-title":"The Aluminium-[18F]Fluoride Revolution: Simple Radiochemistry with a Big Impact for Radio-labelled Biomolecules","volume":"6","author":"Archibald","year":"2021","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"108338","DOI":"10.1016\/j.nucmedbio.2023.108338","article-title":"Direct Comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-Octreotide for PET Imaging of Neuroendocrine Tumors: An-tagonist versus Agonist","volume":"118\u2013119","author":"Ahenkorah","year":"2023","journal-title":"Nucl. Med. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ramonaheng, K., Qebetu, M., Ndlovu, H., Swanepoel, C., Smith, L., Mdanda, S., Mdlophane, A., and Sathekge, M. (2024). Activity Quantification and Dosimetry in Radiopharmaceutical Therapy with Reference to 177Lutetium. Front. Nucl. Med., 4.","DOI":"10.3389\/fnume.2024.1355912"},{"key":"ref_13","first-page":"5247153","article-title":"177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Do-simetry, and Evaluation in Patients with Advanced Prostate Cancer","volume":"2018","author":"Davanzo","year":"2018","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_14","first-page":"687","article-title":"Development of a 177Lu-Labeled RGD Derivative for Targeting Angiogenesis","volume":"25","author":"Ju","year":"2010","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/ijc.32401","article-title":"Trastuzumab Cotreatment Improves Survival of Mice with PC-3 Prostate Cancer Xenografts Treated with the GRPR Antagonist 177 Lu-DOTAGA-PEG2 -RM26","volume":"145","author":"Mitran","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1021\/cr500171e","article-title":"Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radi-ochemistry, and Practical Applications","volume":"115","author":"Banerjee","year":"2015","journal-title":"Chem. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.7150\/thno.75336","article-title":"3p-C-NETA: A Versatile and Effective Chelator for Development of Al18F-Labeled and Therapeutic Radio-pharmaceuticals","volume":"12","author":"Ahenkorah","year":"2022","journal-title":"Theranostics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00775-015-1318-7","article-title":"Promising Bifunctional Chelators for Copper 64-PET Imaging: Practical 64Cu Radiolabeling and High In Vitro and In Vivo Complex Stability","volume":"21","author":"Wu","year":"2016","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1039\/C0CC05707J","article-title":"A Highly Effective Bi-functional Ligand for Radioimmunotherapy Applications","volume":"47","author":"Chong","year":"2011","journal-title":"Chem. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.nucmedbio.2013.01.012","article-title":"Preclinical Evaluation of NETA-Based Bifunctional Ligand for Radioimmunotherapy Applications Using 212Bi and 213Bi: Radiolabeling, Serum Stability, and Biodistribution and Tumor Uptake Studies","volume":"40","author":"Kang","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"112267","DOI":"10.1016\/j.jinorgbio.2023.112267","article-title":"Design and Synthesis of a New Bifunctional Chelating Agent: Application for Al 18F\/177Lu Complexation","volume":"246","author":"Katalin","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"ref_22","unstructured":"Wagner, L. (2023). \u00c9laboration de Ch\u00e9latant Bifonctionnel Original Utilisable en Theranostic pour le Radiomarquage de Bio-Mol\u00e9cules. [Ph.D. Thesis, Universit\u00e9 de Lorraine]."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ddr.21515","article-title":"Structure\u2013Activity Study of Fluorine or Chlorine-Substituted Cinnamic Acid Derivatives with Tertiary Amine Side Chain in Acetylcholinesterase and Butyrylcholinesterase Inhibition","volume":"80","author":"Gao","year":"2019","journal-title":"Drug Dev. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ddr.21726","article-title":"Nitrogen-Containing Flavonoid and Their Analogs with Diverse B-Ring in Acetylcholinesterase and Butyrylcholinesterase Inhibition","volume":"81","author":"Lu","year":"2020","journal-title":"Drug Dev. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Feng, C., Wang, Y., Xu, J., Zheng, Y., Zhou, W., Wang, Y., and Luo, C. (2024). Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121582"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9732","DOI":"10.1039\/c1cc13151f","article-title":"Stable Aluminium Fluoride Chelates with Triazacyclononane Derivatives Proved by X-Ray Crystallography and 18F-Labeling Study","volume":"47","author":"Shetty","year":"2011","journal-title":"Chem. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/cc050043h","article-title":"Aza-Amino Acid Scanning of Secondary Structure Suited for Solid-Phase Peptide Synthesis with Fmoc Chemistry and Aza-Amino Acids with Heteroatomic Side Chains","volume":"7","author":"Boeglin","year":"2005","journal-title":"J. Comb. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/jo300311q","article-title":"Cyclic Aza-Peptide Integrin Ligand Synthesis and Biological Activity","volume":"77","author":"Spiegel","year":"2012","journal-title":"J. Org. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1021\/acs.orglett.8b02449","article-title":"N, N\u2019-Di(Acylamino)-2,5-Diketopiperazines: Strategic Incorporation of Reciprocal n \u2192 \u03a0* Interactions in a Druglike Scaffold","volume":"20","author":"Rahim","year":"2018","journal-title":"Org. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pieve, C.D., Makarem, A., Turnock, S., Maczynska, J., Smith, G., and Kramer-Marek, G. (2020). Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [18F]AlF-Affibody Conjugates. Molecules, 25.","DOI":"10.3390\/molecules25071562"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/acs.chemrev.8b00294","article-title":"Radioactive Main Group and Rare Earth Metals for Imaging and Therapy","volume":"119","author":"Kostelnik","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2191-219X-3-36","article-title":"Radiofluorination Using Aluminum-Fluoride (Al18F)","volume":"3","author":"McBride","year":"2013","journal-title":"EJNMMI Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1021\/bc200175c","article-title":"High-Yielding Aqueous 18F-Labeling of Peptides via Al18F Chelation","volume":"22","author":"McBride","year":"2011","journal-title":"Bioconjug Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Larenkov, A., Mitrofanov, I., and Rakhimov, M. (2024). Improvement of End-of-Synthesis Radiochemical Purity of 177Lu-DOTA-PSMA-Ligands with Alternative Synthesis Approaches: Conversion Upswing and Side-Products Minimization. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121535"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5430\/ijdi.v1n1p5","article-title":"Aspects on Radiolabeling of 177Lu-DOTA-TATE: After C18 Purification Re-Addition of Ascorbic Acid Is Required to Maintain Radiochemical Purity","volume":"1","author":"Maus","year":"2014","journal-title":"Int. J. Diagn. Imaging"},{"key":"ref_36","unstructured":"De Palo, F., Fugazza, L., Barbato, D., Mariani, M., Chicco, D., Tesoriere, G., and Brambati, C. (2020). Stable, Concentrated Radionuclide Complex Solutions. (WO2020021310A1)."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.apradiso.2015.04.016","article-title":"Fully Automated Produc-tion of Sodium [18F]Fluoride on AllInOne and miniAllInOne Synthesizers","volume":"102","author":"Collet","year":"2015","journal-title":"Appl. Radiat. Isot."},{"key":"ref_38","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Petersson, G.A., and Nakatsuji, H. (2019). Gaussian 16, Revision C.01, Gaussian, Inc."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Guo, X., Zhang, X., Li, M., Peng, Y., Wang, Z., and Liu, J. (2024). Preliminary Screening of Biomarkers and Drug Candidates in a Mouse Model of \u03b2-Thalassemia Based on Quasi-Targeted Metabolomics. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1452558"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7421\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:14:10Z","timestamp":1787285650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":39,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167421"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167421","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}